Glaxo has bird flu ‘breakthrough’

BBC News reports here: UK drugs firm GlaxoSmithKline believes it has developed a vaccine for the H5N1 deadly strain of bird flu that may be capable of being mass produced by 2007.

This entry was posted on Wednesday, July 26th, 2006 at 7:39 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.